| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Tumorbiologie und Krebsforschung der Universität Wien, Borschkegasse 8A, A-1090 Vienna [W. H., B. K-G., R. S-H.], and Institut für Biochemie der Universität Graz, Schubertstrasse 1, A-8010 Graz [H. E.], Austria
Recently old rats were found to be much more susceptible than young rats to the hepatocarcinogenic effect of a 5559-week treatment with the peroxisome proliferator nafenopin (NAF) (B. Kraupp-Grasl, W. Huber, H. Taper, and R. Schulte-Hermann, Cancer Res., 51: 666671, 1991). In the present study indicators of oxidative stress were measured in the livers of the same animals (male Wistar). NAF enhanced peroxisomal ß-oxidation 1012-fold and reduced glutathione peroxidase activity by 4050%. Indicators of lipid peroxidation like thiobarbituric acid reactive substances and malondialdehyde were both decreased by one-third and two-thirds, respectively. Of the oxidation-sensitive polyunsaturated fatty acids linoleic acid and docosahexaenoic acid were decreased by 40% and two-thirds, respectively, but the particularly sensitive arachidonic acid remained unchanged. Taken together these data suggest that NAF did not significantly enhance lipid peroxidation in the present experiment. All NAF effects were of the same magnitude in the old and young animals. Therefore, the considerably stronger induction of hepatocarcinoma by NAF in the old animals was not associated with evidence of enhanced oxidative stress. These findings are consistent with the hypothesis that NAF acts hepatocarcinogenically by promotion of tumor development from preneoplastic lesions occurring spontaneously with age.
1 This work was supported by the Austrian "Fonds zur Förderung der Wissenschaftlichen Forschung" as Project P-7875-MED.
2 To whom requests for reprints should be addressed.
Received 5/24/90. Accepted 1/22/91.
This article has been cited by other articles:
![]() |
J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate Toxicol. Sci., October 1, 2003; 75(2): 300 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters Toxicol. Sci., September 1, 2002; 69(1): 139 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Isenberg, L. M. Kamendulis, D. C. Ackley, J. H. Smith, G. Pugh Jr., A. W. Lington, R. H. McKee, and J. E. Klaunig Reversibility and Persistence of Di-2-ethylhexyl Phthalate (DEHP)- and Phenobarbital-Induced Hepatocellular Changes in Rodents Toxicol. Sci., December 1, 2001; 64(2): 192 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Isenberg, L. M. Kamendulis, J. H. Smith, D. C. Ackley, G. Pugh Jr., A. W. Lington, and J. E. Klaunig Effects of Di-2-Ethylhexyl Phthalate (DEHP) on Gap-Junctional Intercellular Communication (GJIC), DNA Synthesis, and Peroxisomal Beta Oxidation (PBOX) in Rat, Mouse, and Hamster Liver Toxicol. Sci., July 1, 2000; 56(1): 73 - 85. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |